BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 22678022)

  • 1. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of rabies virus glycoprotein.
    Sun L; Chen Z; Yu L; Wei J; Li C; Jin J; Shen X; Lv X; Tang Q; Li D; Liang M
    Appl Microbiol Biotechnol; 2012 Oct; 96(2):357-66. PubMed ID: 22678022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of Recombinant Human Monoclonal Antibody Cocktail for Post-exposure Rabies Prophylaxis].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):399-403. PubMed ID: 29979531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Generation of Human ScFv Antibodies for Antigenic Site III of Rabies Virus Glycoprotein from Antibody-phage Libraries by Chain Shuffling].
    Sun L; Liu Y; Li C; Li D; Liang M
    Bing Du Xue Bao; 2016 Jul; 32(4):393-8. PubMed ID: 29979522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The development of neutralizing human antibodies against rabies virus].
    Chen Z; Sun LN; Li C; Lv XJ; Tang Q; Liang MF; Li DX
    Bing Du Xue Bao; 2010 Jul; 26(4):271-5. PubMed ID: 20836379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
    Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
    J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries.
    Kramer RA; Marissen WE; Goudsmit J; Visser TJ; Clijsters-Van der Horst M; Bakker AQ; de Jong M; Jongeneelen M; Thijsse S; Backus HH; Rice AB; Weldon WC; Rupprecht CE; Dietzschold B; Bakker AB; de Kruif J
    Eur J Immunol; 2005 Jul; 35(7):2131-45. PubMed ID: 15971273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative effects of a disulfide bond mismatch in anti-rabies G protein single-chain antibody variable fragment FV57.
    Duan Y; Gu T; Zhang X; Jiang C; Yuan R; Li Z; Wang D; Chen X; Wu C; Chen Y; Wu Y; Kong W
    Mol Immunol; 2014 Jun; 59(2):136-41. PubMed ID: 24598312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.
    Houimel M; Dellagi K
    J Virol Methods; 2009 Nov; 161(2):205-15. PubMed ID: 19559727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alanine scanning of the rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment.
    Papaneri AB; Wirblich C; Marissen WE; Schnell MJ
    Vaccine; 2013 Dec; 31(49):5897-902. PubMed ID: 24120673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
    Sloan SE; Hanlon C; Weldon W; Niezgoda M; Blanton J; Self J; Rowley KJ; Mandell RB; Babcock GJ; Thomas WD; Rupprecht CE; Ambrosino DM
    Vaccine; 2007 Apr; 25(15):2800-10. PubMed ID: 17240489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates.
    Wang Y; Rowley KJ; Booth BJ; Sloan SE; Ambrosino DM; Babcock GJ
    Antiviral Res; 2011 Aug; 91(2):187-94. PubMed ID: 21693135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel disulfide-stabilized single-chain variable antibody fragment against rabies virus G protein with enhanced in vivo neutralizing potency.
    Duan Y; Gu TJ; Jiang CL; Yuan RS; Zhang HF; Hou HJ; Yu XH; Chen Y; Zhang Y; Wu YG; Kong W
    Mol Immunol; 2012 Jun; 51(2):188-96. PubMed ID: 22484084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of novel human monoclonal antibodies possessing neutralizing ability against rabies virus.
    Matsumoto T; Yamada K; Noguchi K; Nakajima K; Takada K; Khawplod P; Nishizono A
    Microbiol Immunol; 2010 Nov; 54(11):673-83. PubMed ID: 21044141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
    Prosniak M; Faber M; Hanlon CA; Rupprecht CE; Hooper DC; Dietzschold B
    J Infect Dis; 2003 Jul; 188(1):53-6. PubMed ID: 12825170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel variable antibody fragment dimerized by leucine zippers with enhanced neutralizing potency against rabies virus G protein compared to its corresponding single-chain variable antibody fragment.
    Li Z; Cheng Y; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
    Mol Immunol; 2015 Dec; 68(2 Pt A):168-75. PubMed ID: 26325475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of the human neutralizing antibody fragment Fab091 against rabies virus.
    Li C; Zhang F; Lin H; Wang ZC; Liu XJ; Feng ZQ; Zhu J; Guan XH
    Acta Pharmacol Sin; 2011 Mar; 32(3):329-37. PubMed ID: 21278782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis.
    Kim PK; Ahn JS; Kim CM; Seo JM; Keum SJ; Lee HJ; Choo MJ; Kim MS; Lee JY; Maeng KE; Shin JY; Yi KS; Osinubi MOV; Franka R; Greenberg L; Shampur M; Rupprecht CE; Lee SY
    PLoS One; 2021; 16(9):e0256779. PubMed ID: 34469480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection and affinity maturation of human antibodies against rabies virus from a scFv gene library using ribosome display.
    Zhao XL; Chen WQ; Yang ZH; Li JM; Zhang SJ; Tian LF
    J Biotechnol; 2009 Dec; 144(4):253-8. PubMed ID: 19818816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A VL-linker-VH Orientation Dependent Single Chain Variable Antibody Fragment Against Rabies Virus G Protein with Enhanced Neutralizing Potency in vivo.
    Cheng Y; Li Z; Xi H; Gu T; Yuan R; Chen X; Jiang C; Kong W; Wu Y
    Protein Pept Lett; 2016; 23(1):24-32. PubMed ID: 26497316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.